Randomized clinical trial of daclizumab
โ
C. H. Wilson; N. R. Brook; M. A. Gok; J. F. Asher; M. L. Nicholson; D. Talbot
๐
Article
๐
2005
๐
John Wiley and Sons
๐
English
โ 116 KB
## Abstract ## Background Kidneys from non-heart-beating donors (NHBDs) have high rates of delayed graft function (DGF). Use of calcineurin inhibitors is associated with a reduction in renal blood flow, which may delay graft recovery from ischaemic acute tubular necrosis. ## Methods To assess wh